Scarica l'app Stockscreener
175.10
3.07%
-5.54
Dopo l'orario di chiusura:
175.50
0.40
+0.23%
Precedente Chiudi:
$180.64
Aprire:
$176.11
Volume 24 ore:
354.34K
Relative Volume:
27.55
Capitalizzazione di mercato:
$18.65B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$175.00
$180.40
Intervallo di 1 settimana:
$175.00
$184.76
Portata 52W:
$175.00
$184.76
Beigene Ltd Adr Stock (ONC) Company Profile
Nome
Beigene Ltd Adr
Settore
Industria
Telefono
13459494123
Indirizzo
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
Confronta ONC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONC
Beigene Ltd Adr
|
175.10 | 18.65B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.32 | 105.15B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
730.30 | 80.25B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
648.62 | 38.79B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.95 | 30.43B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
126.88 | 30.42B | 3.30B | -501.07M | 1.03B | -2.1146 |
Beigene Ltd Adr Stock (ONC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-03 | Ripresa | Morgan Stanley | Overweight |
| 2024-09-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-02-06 | Ripresa | JP Morgan | Overweight |
| 2023-09-12 | Iniziato | Macquarie | Outperform |
| 2023-08-17 | Iniziato | Jefferies | Buy |
| 2023-07-17 | Iniziato | Citigroup | Buy |
| 2023-06-30 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | Iniziato | Daiwa Securities | Buy |
| 2022-10-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-13 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | Ripresa | JP Morgan | Overweight |
| 2022-03-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | Iniziato | Deutsche Bank | Buy |
| 2021-10-12 | Iniziato | Bernstein | Outperform |
| 2021-10-06 | Aggiornamento | CLSA | Underperform → Buy |
| 2021-03-08 | Iniziato | China Renaissance | Buy |
| 2021-03-01 | Downgrade | CLSA | Outperform → Underperform |
| 2020-11-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | Downgrade | Maxim Group | Buy → Hold |
| 2020-11-06 | Downgrade | Piper Sandler | Neutral → Underweight |
Mostra tutto
Beigene Ltd Adr Borsa (ONC) Ultime notizie
(NASDAQ:BGNE) Stock Quotes, Forecast and News Summary - Benzinga
FDA approves BeiGene's TEVIMBRA for advanced gastric cancer treatment - Investing.com
Weekly Upgrades and Downgrades - InvestorPlace
BeiGene shares reiterate Buy rating on robust oncology pipeline - Investing.com
Beigene directors sell shares worth $194.2 million - Investing.com
10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey
10 Biggest Biotechnology Companies - Investopedia
BeiGene announces passing of board member Donald Glazer - Investing.com
BeiGene stock momentum builds on Brukinsa success, says JPMorgan's Fye - Investing.com
BeiGene CEO John Oyler sells shares worth over $3.75 million - Investing.com
BeiGene's SVP sells shares worth nearly $285k - Investing.com
BeiGene executive sells over $1.1m in company shares - Investing.com
CCBI Lowers BEIGENE (06160.HK) TP to $140, Solid 2Q Results Expected - AASTOCKS.com
Nomura Raises BEIGENE (06160.HK)'s TP to $158.37 and Rev. Forecast for FY24/FY25 - AASTOCKS.com
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why - Yahoo Finance
Primecap Odyssey Funds' 2023 Semiannual Letter - GuruFocus.com
Making it harder to "buy" China, Inc. - US-China Institute
What Happens to Your ETFs if Chinese ADRs Delist? - HK.Morningstar.com
Will We See a Slew of ADR Delistings? - HK.Morningstar.com
See What the Public Investment Fund Bought Recently Including Walmart and FedEx Stocks - Sovereign Wealth Fund Institute
BeiGene (BGNE) Gets FDA Nod for Brukinsa Label Expansion - Yahoo Finance
BeiGene Ltd. Sponsored ADR to Host Earnings Call - AccessWire
Beigene Ltd Adr Azioni (ONC) Dati Finanziari
Non sono disponibili dati finanziari per Beigene Ltd Adr (ONC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
11.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):